Attitude and influencing factors to receive the COVID-19 vaccine among university students in Sichuan Province, China: A cross-sectional study.

Publisher: John Wiley & Sons, Inc Country of Publication: United States NLM ID: 101675107 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2054-1058 (Electronic) Linking ISSN: 20541058 NLM ISO Abbreviation: Nurs Open Subsets: MEDLINE

Original Publication: [Hoboken, NJ] : John Wiley & Sons, Inc., [2014]-

COVID-19*/epidemiology ; COVID-19*/prevention & control ; COVID-19 Vaccines*/administration & dosage ; Vaccination Hesitancy* ; Students*/psychology; Humans ; Cross-Sectional Studies ; Universities ; China ; Pandemics ; Adult

Aims: To explore the university students' attitude and the potential influencing factors to receive the coronavirus disease 2019 (COVID-19) vaccine in Sichuan Province, China.
Design: A cross-sectional study.
Methods: The self-designed questionnaire was distributed among university students online in June 2021. SPSS software was used for statistical analysis of the data. Descriptive statistics, Chi-square, two independent samples t-tests, one-way analysis of variance (ANOVA), multivariate linear regression, and content analysis were performed.
Results: A total of 397 questionnaires were analysed, involving 316 (79.6%) respondents have received at least one dose of a COVID-19 vaccine and 81 (20.4%) have not taken the vaccine. The total mean score of university students' vaccination attitude was 25.97 (standard deviation [SD] = 3.720), and the total scoring rate was 74.2%. Main factors influencing students' attitude included education level, major, living style, with chronic disease or not, self-reported vaccination status, and number of medical units that can provide vaccination within 3 km of residence. Students were more willing to choose Chinese-manufactured vaccines (66.8%) and participate in collective vaccination programs organized by the school (71.3%). The desired vaccine protection period was 5-10 years (42.1%). The top three reasons for refusing the vaccine or vaccine hesitancy were as follows: concern about the side effects of vaccine (44.8%), lack of information about vaccine (31.0%), and concern about the efficacy of vaccine (29.3%).
Conclusion: In general, most of the participants had relatively high level of positive attitude to receive the COVID-19 vaccine. Nevertheless, more attention should be paid to postgraduate students, non-medical students, those living alone, those with chronic disease, those have not received the COVID-19 vaccine, and those living far away from the vaccination medical units. Findings of this study can help educational institutions in developing effective interventions to improve the vaccination rate in the university student population.
(© 2023 The Authors. Nursing Open published by John Wiley & Sons Ltd.)

Vaccine. 2022 May 11;40(22):3046-3054. (PMID: 35450782)
Disaster Med Public Health Prep. 2022 Jun;16(3):1134-1140. (PMID: 34346308)
J Physiol Pharmacol. 2022 Apr;73(2):. (PMID: 36193970)
Dialogues Health. 2022 Dec;1:100005. (PMID: 36785633)
Health Serv Res Manag Epidemiol. 2022 May 3;9:23333928221098903. (PMID: 35528024)
Lancet. 2020 Feb 15;395(10223):497-506. (PMID: 31986264)
Z Gesundh Wiss. 2022;30(10):2441-2448. (PMID: 34055572)
Vaccines (Basel). 2021 Jun 14;9(6):. (PMID: 34198716)
J Family Med Prim Care. 2022 Jan;11(1):224-232. (PMID: 35309633)
Front Public Health. 2022 Jan 06;9:777565. (PMID: 35071162)
Front Public Health. 2022 Feb 08;10:796467. (PMID: 35211440)
Vaccines (Basel). 2021 Aug 25;9(9):. (PMID: 34579185)
Vaccines (Basel). 2021 Jun 15;9(6):. (PMID: 34203847)
PLoS One. 2021 Aug 3;16(8):e0255447. (PMID: 34343202)
Child Abuse Negl. 2017 Jan;63:183-191. (PMID: 27930959)
Int J Environ Res Public Health. 2021 Mar 01;18(5):. (PMID: 33804558)
Trop Med Health. 2021 May 13;49(1):37. (PMID: 33985592)
Front Public Health. 2021 Dec 15;9:735902. (PMID: 34976911)
Vaccine. 2020 Sep 29;38(42):6500-6507. (PMID: 32863069)
Nat Med. 2021 Aug;27(8):1385-1394. (PMID: 34272499)
Clin Exp Vaccine Res. 2022 Sep;11(3):274-284. (PMID: 36451669)
Nurs Open. 2023 Aug;10(8):5149-5164. (PMID: 37071667)
Nurse Educ Pract. 2021 Aug;55:103148. (PMID: 34311170)
Front Psychol. 2022 May 19;13:876116. (PMID: 35664204)
PLoS One. 2022 Feb 11;17(2):e0262305. (PMID: 35148317)
Tunis Med. 2022 mars;100(3):222-228. (PMID: 36005914)
Vaccine. 2022 Apr 6;40(16):2442-2456. (PMID: 35305823)
Epidemiol Infect. 2021 Nov 02;149:e242. (PMID: 34726141)
Saudi J Biol Sci. 2022 Apr;29(4):2314-2322. (PMID: 34899014)
Vaccine. 2021 May 18;39(21):2833-2842. (PMID: 33896661)
Hum Vaccin Immunother. 2022 Nov 30;18(5):2073757. (PMID: 35612817)
Nat Rev Immunol. 2021 Feb;21(2):73-82. (PMID: 33340022)
Vaccines (Basel). 2020 Aug 27;8(3):. (PMID: 32867224)
Healthcare (Basel). 2021 Jun 22;9(7):. (PMID: 34206217)
PLoS Negl Trop Dis. 2020 Dec 17;14(12):e0008961. (PMID: 33332359)
Front Public Health. 2022 Jun 03;10:869838. (PMID: 35719679)
Vaccine. 2014 Apr 17;32(19):2150-9. (PMID: 24598724)
J Adv Nurs. 2021 Apr;77(4):1839-1855. (PMID: 33259651)
Vaccines (Basel). 2021 Jan 12;9(1):. (PMID: 33445581)
J Multidiscip Healthc. 2022 Jan 11;15:81-92. (PMID: 35046663)
Eur J Epidemiol. 2020 Aug;35(8):781-783. (PMID: 32761440)
J Am Coll Health. 2022 Sep 15;:1-7. (PMID: 36107804)
BMC Psychiatry. 2023 Feb 7;23(1):97. (PMID: 36750821)
Saf Sci. 2021 Jun;138:105236. (PMID: 33678991)
Immunity. 2020 May 19;52(5):737-741. (PMID: 32433946)
Front Public Health. 2022 Dec 15;10:1098911. (PMID: 36589983)
Hum Vaccin Immunother. 2021 Dec 2;17(12):4914-4924. (PMID: 35061570)
Front Public Health. 2022 May 11;10:865571. (PMID: 35646770)
Curr Med Sci. 2021 Dec;41(6):1037-1051. (PMID: 34241776)
Lancet Reg Health Eur. 2021 Feb;1:100012. (PMID: 33954296)
Front Microbiol. 2020 Mar 17;11:372. (PMID: 32256465)
J Integr Med. 2022 Jan;20(1):1-3. (PMID: 34896048)
Blood Purif. 2021;50(6):740-749. (PMID: 33752209)
J Infect Public Health. 2021 Oct;14(10):1481-1488. (PMID: 34247946)

Keywords: COVID-19; attitude; influencing factor; university student; vaccine

0 (COVID-19 Vaccines)

Date Created: 20230418 Date Completed: 20230728 Latest Revision: 20230728

20230728

PMC10333833

10.1002/nop2.1751

37071667